查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1808628

呼吸诊断市场（按诊断测试、患者人口统计、产品和最终用户）—2025-2030 年全球预测

Respiratory Diagnostics Market by Diagnostic Tests, Patient Demographics, Offerings, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计呼吸诊断市场规模到 2024 年将达到 66.6 亿美元，到 2025 年将达到 72.6 亿美元，到 2030 年将达到 109.7 亿美元，复合年增长率为 8.66%。

主要市场统计数据
基准年2024年 66.6亿美元
预计2025年 72.6亿美元
预测年份 2030 109.7亿美元
复合年增长率（%） 8.66%

利用新技术和监管趋势引领复杂的呼吸诊断环境，引领未来发展

在技​​术创新和全球健康紧迫性的双重推动下，呼吸诊断市场正经历前所未有的成长。随着慢性呼吸系统疾病盛行率的上升和患者意识的增强，该行业已进入一个充满活力的变革阶段。先进的分析工具、照护现场设备和数位健康平台正在融合，以创造更准确、更快速、更方便的诊断途径。此外，关键市场不断变化的监管要求也带来了新的合规挑战，需要在整个价值链中製定适应性策略。

探索后疫情时代塑造呼吸诊断生态系统的关键技术与业务转型

近年来，数位健康与人工智慧融合的突破性进展，彻底改变了呼吸诊断领域。机器学习演算法如今支援高解析度影像解读，使临床医生能够更准确地发现早期异常。同时，云端基础的分析平台能够跨多个接触点无缝聚合患者数据，从而更全面地洞察病情进展。这种转变不仅缩短了诊断时间，也降低了整体营运成本。

2025年美国关税实施对供应链、成本结构和市场适应性的综合影响分析

2025年美国关税调整对全球呼吸诊断供应链产生了重大影响。进口零件面临关税上调，迫使设备製造商重新评估筹资策略和合作伙伴网路。结果，製造成本大幅上升，尤其是高精度诊断成像系统和先进的分子检测套件。为此，几家主要製造商推行近岸外包，将组装迁至更靠近终端市场的地方，以减轻关税的影响并确保交付的连续性。

各种市场细分观点，重点在于测试模式、人口统计、解决方案产品和最终用户应用

仔细观察诊断测试方式就会发现，动脉血气分析和全血球计数等血液评估仍然是评估呼吸功能和识别全身性发炎的基本工具。胸部 X 光、 电脑断层扫描和 MRI 扫描等诊断影像平台仍然是可视化结构异常的重要工具。同时，肺功能测试（例如肺量计、弥散能力测量和肺活量评估）对于追踪疾病进展和指导治疗性介入介入至关重要。先进的分子测试（例如 PCR 检测、抗原检测和生物标记分析）进一步提高了诊断准确性，而脉搏血氧计和痰液分析方案则有助于在临床和家庭环境中进行持续监测。

分析美洲、欧洲、中东和非洲以及亚太地区呼吸诊断领域的区域成长动力和市场趋势

呼吸诊断的区域动态因医疗基础设施的成熟度、法规环境和经济因素而明显不同。在美洲，先进的临床网络和广泛的报销体係正在推动高端成像系统和分子诊断的快速普及，而研究资金和公共卫生计划则进一步推动了市场发展势头。欧洲、中东和非洲地区呈现出多元化的环境，西欧市场专注于技术成熟度和严格的监管合规性，而中东和北非地区国家则透过官民合作关係和有针对性的疾病筛检计画来提昇能力。

揭示影响呼吸诊断领域发展的主要企业的竞争动态和创新策略

呼吸诊断领域的主要企业正专注于多项关键策略，以保持竞争优势。诊断影像系统製造商和软体分析供应商之间正在形成策略联盟，将硬体创新与先进的数据解读演算法相结合。这种协作方式正在加速整合诊断平台的部署，从而实现无缝资料交换和远端存取。同时，大型诊断集团对利基分子检测开发商的收购正在增强其检测产品组合，并扩大疾病检测和个人化治疗计划的范围。

提供富有洞察力的策略指南，以增强呼吸诊断产业的创新、协作和营运弹性

为了抓住市场机会，产业领导者应优先投资可互通的数位平台，这些平台能够整合各种诊断资料流，并支援即时决策。与软体开发商和学术机构建立协作生态系统，使企业能够共同打造先进的分析解决方案，从而始终领先于不断变化的临床需求。同时，透过双重采购和近岸外包实现供应链多元化，可以缓解关税相关的中断，并确保设备供应的持续稳定。

阐明一个严格的多阶段研究框架，整合初步检验和次要分析，以获得可靠的呼吸诊断情报

本研究采用全面的多阶段方法，以确保最高的准确性和可靠性。原始资料收集包括与关键意见领袖（包括肺科医生、实验室主任和监管专家）进行全面访谈，以获得关于新兴趋势、临床工作流程和采购驱动因素的第一手见解。这些定性研究结果与已发表文献、技术白皮书和监管资料库的深入审查相辅相成，从而提供了坚实的二手资料基础。

综合关键发现与未来发展轨迹，指导呼吸诊断业务的策略发展与产业前景

综上所述，本摘要概述的关键洞察表明，呼吸诊断领域正在进入一个由数位整合、策略供应链重组和协作创新定义的时代。先进成像平台与分子检测之间的相互作用，正在推动人们对呼吸系统疾病的更深入理解。同时，监理改革和关税政策凸显了营运敏捷性和积极主动的相关人员参与的重要性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章市场动态

  • 越来越多地采用即时分子检测来快速识别呼吸道病原体
  • 将人工智慧驱动的演算法整合到肺功能测试中以实现早期疾病检测
  • 使用可连接智慧型手机的家用肺量计设备监测慢性阻塞性肺病激增
  • 增加对可携式气溶胶分析平台的投资，用于即时监测空气传播的病原体
  • 多重即时PCR检测板的出现，可同时检测多种呼吸道病毒
  • 扩展基于 CRISPR 的检测方法，以便在临床环境中灵敏地检测新兴呼吸道病原体
  • 呼吸组学技术的发展，用于呼吸系统疾病诊断中的非侵入性生物标记分析

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

8. 呼吸诊断市场（依诊断检验）

  • 血液检查
    • 动脉血气
    • 全血球计数
  • 影像检查
    • 胸部X光检查
    • 电脑断层扫描
    • 核磁共振扫描
  • 肺功能检查
    • 扩散容量测试
    • 肺容量测试
    • 肺量计
  • 分子检测
    • 抗原检测
    • 生物标记检测
    • PCR检测
  • 脉搏血氧计
  • 痰液检查

第九章呼吸诊断市场（依患者人口统计）

  • 成人
  • 老年人
  • 孩子们

第 10 章呼吸诊断市场（按产品提供）

  • 装置
    • 容积描记器
    • 诊断影像系统
    • 气体分析仪
    • 肺量计系统
  • 服务
  • 软体
    • 数据分析软体
    • 影像分析软体
    • 肺功能测试（PFT）软体

第 11 章呼吸诊断市场（依最终用户）

  • 学术机构
  • 诊断实验室
  • 医院和诊所
  • 研究所

12.美洲呼吸诊断市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

13. 欧洲、中东和非洲呼吸诊断市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

14.亚太呼吸诊断市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Becton, Dickinson, and Company
    • Abbott Laboratories
    • Adaltis Srl
    • Altona Diagnostics GmbH
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Bioneer Corporation
    • CerTest Biotec SL
    • Daan Gene Co., Ltd.
    • Diatech Pharmacogenetics srl
    • Dragerwerk AG & Co. KGaA
    • F. Hoffmann-La Roche Ltd.
    • GE HealthCare Technologies, Inc.
    • Hologic, Inc.
    • Johnson & Johnson Services, Inc.
    • Koninklijke Philips NV
    • Masimo Corporation
    • Medtronic PLC
    • Merck KGaA
    • ProAxsis by NetScientific PLC
    • Quest Diagnostics Incorporated
    • Quidel Corporation
    • Sansure Biotech Inc.
    • SDI Diagnostics, Inc.
    • Seegene Inc.
    • Siemens Healthineers AG
    • ResMed Corp.
    • Thermo Fisher Scientific Inc.
    • Vitalograph Ltd.
    • ZeptoMetrix LLC

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

Product Code: MRR-894699F5EBCB

The Respiratory Diagnostics Market was valued at USD 6.66 billion in 2024 and is projected to grow to USD 7.26 billion in 2025, with a CAGR of 8.66%, reaching USD 10.97 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 6.66 billion
Estimated Year [2025] USD 7.26 billion
Forecast Year [2030] USD 10.97 billion
CAGR (%) 8.66%

Navigating the Complex Respiratory Diagnostics Environment with Emerging Technologies and Regulatory Dynamics Steering Future Developments

The respiratory diagnostics landscape has experienced an unprecedented surge in both technological innovation and global health urgency. Driven by rising prevalence of chronic respiratory conditions and heightened patient awareness, the industry has entered a phase of dynamic evolution. Advanced analytical tools, point-of-care devices, and digital health platforms are converging to create more precise, rapid, and accessible diagnostic pathways. Moreover, shifting regulatory requirements across major markets have introduced new compliance challenges, necessitating adaptive strategies across the entire value chain.

Amid these complexities, this report provides a comprehensive exploration of the key market forces influencing respiratory diagnostics. It paints a clear picture of how technological breakthroughs are intersecting with demographic trends, healthcare protocols, and reimbursement frameworks. By establishing a foundational understanding of current drivers and barriers, this introduction sets the stage for deeper analysis. As you navigate this landscape, the insights presented here will illuminate strategic opportunities and potential pitfalls, empowering decision-makers to chart a forward-looking course in an increasingly competitive environment.

Exploring Pivotal Technological and Operational Transformations Reshaping the Respiratory Diagnostics Ecosystem in a Post-Pandemic Era

Over the past several years, respiratory diagnostics has been transformed by breakthroughs in digital health and the integration of artificial intelligence. Machine learning algorithms now support high-resolution imaging interpretation, enabling clinicians to detect early-stage anomalies with greater accuracy. Meanwhile, cloud-based analytics platforms facilitate the seamless aggregation of patient data across multiple touchpoints, offering more holistic insights into disease progression. These shifts have not only accelerated diagnostic timelines but also lowered overall operational costs.

In addition to technological advances, the industry is experiencing a paradigm shift toward decentralized care models. Point-of-care testing solutions are proliferating beyond hospital settings into community clinics and home-based environments. This expansion is accompanied by growing emphasis on patient empowerment and remote monitoring, which together foster proactive disease management. Consequently, manufacturers and service providers are increasingly focusing on modular, portable solutions that can adapt to a range of clinical workflows. These transformative forces are redefining traditional value chains, encouraging stakeholders to adopt agile development and collaborative partnerships.

Analyzing the Compound Effects of United States Tariff Implementations in 2025 on Supply Chains, Cost Structures, and Market Adaptations

The United States' tariff adjustments implemented in 2025 have exerted a considerable influence on the global respiratory diagnostics supply chain. Imported components faced elevated duties, prompting device manufacturers to reassess sourcing strategies and partner networks. As a result, production costs experienced a noticeable escalation, particularly for high-precision imaging systems and advanced molecular assay kits. In response, several key players pursued nearshoring initiatives, relocating assembly lines closer to end markets to mitigate duty impacts and ensure delivery continuity.

Beyond immediate cost implications, these tariff measures have catalyzed broader strategic realignments. Organizations have intensified supplier diversification efforts to reduce dependency on any single geographic region. Concurrently, there has been a surge in investment toward local manufacturing capabilities and quality control infrastructure. These adjustments have not only buffered the effects of trade policy volatility but also fostered resilience in the face of future disruptions. Overall, the cumulative impact of the 2025 tariff regime underscores the critical importance of supply chain agility and strategic foresight in managing regulatory headwinds.

Unpacking Diverse Market Segmentation Perspectives Highlighting Test Modalities, Demographic Cohorts, Solution Offerings, and End-User Applications

An in-depth look at diagnostic test modalities reveals that blood-based assessments such as arterial blood gas analysis and complete blood count remain foundational tools for evaluating respiratory function and identifying systemic inflammation. Imaging platforms spanning chest X-rays, CT scans, and MRI scans continue to serve as critical modalities for visualizing structural abnormalities. At the same time, lung function tests like spirometry, diffusion capacity measurements, and lung volume assessments are essential for tracking disease progression and guiding therapeutic interventions. Advanced molecular tests including PCR assays, antigen detection, and biomarker profiling further enrich diagnostic accuracy, while pulse oximetry and sputum analysis protocols facilitate ongoing monitoring in both clinical and at-home settings.

Patient demographic segmentation highlights how adult populations drive baseline demand, while geriatric cohorts increasingly rely on complex diagnostic combinations to manage age-related pulmonary disorders. Pediatric segments, by contrast, often prioritize minimally invasive and radiation-free techniques, aligning with safety considerations. Examining market offerings underscores that equipment portfolios-ranging from spirometry systems and gas analyzers to body plethysmographs and diagnostic imaging units-form the backbone of capital investment. Complementary services such as calibration, maintenance, and clinical support services reinforce equipment performance. Meanwhile, specialized software solutions offering data analytics, imaging processing, and pulmonary function testing management are gaining traction as indispensable components of integrated diagnostic ecosystems. Finally, end-user analysis indicates that hospitals and clinics represent the primary consumption hubs, followed by diagnostic laboratories, research institutes, and academic institutions, each driving tailored requirements for throughput, data integration, and reporting capabilities.

Dissecting Regional Growth Drivers and Market Nuances across the Americas, Europe Middle East Africa, and Asia-Pacific Respiratory Diagnostics Arenas

Regional dynamics in respiratory diagnostics exhibit clear differentiation driven by healthcare infrastructure maturity, regulatory environments, and economic factors. In the Americas, advanced clinical networks and expansive reimbursement regimes catalyze rapid adoption of high-end imaging systems and molecular diagnostics. Meanwhile, research funding and public health initiatives further strengthen market momentum. The Europe, Middle East, and Africa region presents a multifaceted environment where Western European markets emphasize technological sophistication and stringent regulatory compliance, while Middle Eastern and African nations pursue capacity building through public-private partnerships and targeted disease screening programs.

Asia-Pacific stands out for its diverse market trajectories, as developed economies such as Japan and Australia leverage digital health integration, whereas emerging markets prioritize cost-effective, portable testing solutions to broaden diagnostic reach. Government-led health campaigns and expanding private sector participation are key drivers of growth across the region. Collectively, these regional nuances underscore the importance of tailored go-to-market strategies that align with local regulatory frameworks, reimbursement landscapes, and healthcare delivery models.

Illuminating Competitive Dynamics and Innovation Strategies Employed by Leading Enterprises Shaping the Respiratory Diagnostics Sector's Evolution

Leading organizations within the respiratory diagnostics sphere have converged on a few critical strategies to maintain competitive advantage. Strategic partnerships between imaging system manufacturers and software analytics providers have emerged, combining hardware innovations with advanced data interpretation algorithms. This collaborative approach has accelerated the roll-out of integrated diagnostic platforms capable of seamless data exchange and remote accessibility. Simultaneously, acquisitions of niche molecular assay developers by large diagnostic conglomerates have bolstered assay portfolios, enhancing the scope of disease detection and personalized treatment planning.

New entrants differentiate through agile business models, offering subscription-based or as-a-service equipment deployment to reduce capital expenditure burdens on healthcare providers. Additionally, several companies have established centers of excellence in emerging markets to support localized R&D and regulatory approvals. The focus on continuous product lifecycle management, guided by post-market surveillance and real-world evidence collection, further demonstrates how top-tier players are leveraging data-driven feedback loops to refine their offerings. These collective competitive maneuvers illustrate a sector characterized by rapid consolidation, innovation-driven partnerships, and evolving commercial frameworks.

Delivering Insightful Strategic Imperatives to Enhance Innovation, Collaboration, and Operational Resilience within the Respiratory Diagnostics Industry

To capitalize on market opportunities, industry leaders should prioritize investment in interoperable digital platforms that integrate diverse diagnostic data streams, enabling real-time decision support. By fostering collaborative ecosystems with software developers and academic institutions, organizations can co-create advanced analytics solutions that anticipate evolving clinical needs. Concurrently, diversifying supply chains through dual sourcing and nearshoring can mitigate tariff-related disruptions and ensure consistent device availability.

Moreover, pursuing modular product designs will allow rapid customization for distinct end-user environments, from high-throughput hospital labs to decentralized community clinics. Engaging proactively with regulatory authorities and participating in standards-development consortia will streamline approval pathways and set benchmarks for quality and safety. Finally, embedding sustainability principles into manufacturing and packaging processes will not only address environmental concerns but also resonate with increasingly value-driven procurement practices. Taken together, these recommendations form a cohesive blueprint for sustaining growth and maintaining competitive differentiation within the respiratory diagnostics landscape.

Elucidating a Rigorous Multi-Phased Research Framework Integrating Primary Validation and Secondary Analysis for Robust Respiratory Diagnostics Intelligence

This research employs a meticulous multi-phased approach to ensure the highest level of accuracy and reliability. Primary data collection involved comprehensive interviews with key opinion leaders, including pulmonologists, laboratory directors, and regulatory specialists, to capture firsthand insights on emerging trends, clinical workflows, and procurement drivers. These qualitative findings were supplemented by a detailed review of public filings, technical whitepapers, and regulatory databases, providing a robust secondary data foundation.

Quantitative analysis was conducted through data triangulation methodologies, cross-referencing supply chain metrics, healthcare expenditure reports, and product launch timelines. The resulting data sets underwent rigorous validation, employing statistical techniques to identify outliers and verify consistency. Additionally, a proprietary assessment framework evaluated each technology's maturity, adoption potential, and competitive positioning. This layered research protocol ensures that conclusions are grounded in empirical evidence and reflect the latest evolutions shaping respiratory diagnostics.

Synthesizing Key Discoveries and Future Trajectories to Guide Strategic Progression in Respiratory Diagnostic Endeavors and Sector Perspectives

Drawing together the critical insights outlined throughout this summary, it becomes clear that respiratory diagnostics is entering an era defined by digital integration, strategic supply chain realignment, and collaborative innovation. The interplay between advanced imaging platforms and molecular assays is driving a more nuanced understanding of respiratory pathologies. Simultaneously, regulatory reforms and tariff policies underscore the importance of operational agility and proactive stakeholder engagement.

Looking ahead, organizations that embrace modular, data-driven solutions and cultivate diverse partnerships will be best positioned to navigate market complexities. By applying the strategic imperatives detailed here, decision-makers can capitalize on emerging opportunities, mitigate potential risks, and deliver enhanced patient outcomes. Ultimately, this report offers a roadmap for achieving sustained growth and leadership in a dynamic respiratory diagnostics environment, supporting stakeholders in making informed, future-focused choices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Increasing adoption of point-of-care molecular testing for rapid identification of respiratory pathogens
  • 5.2. Integration of AI-driven algorithms in pulmonary function testing for early disease detection
  • 5.3. Surge in utilization of home-based spirometry devices with smartphone connectivity for chronic obstructive pulmonary disease monitoring
  • 5.4. Rising investments in portable aerosol analysis platforms for real-time monitoring of airborne pathogens
  • 5.5. Emergence of multiplex real-time PCR panels enabling simultaneous detection of multiple respiratory viruses
  • 5.6. Expansion of CRISPR-based assays for highly sensitive detection of emerging respiratory pathogens in clinical settings
  • 5.7. Development of breathomics technology for non-invasive biomarker profiling in respiratory disease diagnosis

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Respiratory Diagnostics Market, by Diagnostic Tests

  • 8.1. Introduction
  • 8.2. Blood Tests
    • 8.2.1. Arterial Blood Gases
    • 8.2.2. Complete Blood Count
  • 8.3. Imaging Tests
    • 8.3.1. Chest X-Rays
    • 8.3.2. CT Scans
    • 8.3.3. MRI Scans
  • 8.4. Lung Function Tests
    • 8.4.1. Diffusion Capacity Tests
    • 8.4.2. Lung Volume Tests
    • 8.4.3. Spirometry
  • 8.5. Molecular Tests
    • 8.5.1. Antigen Tests
    • 8.5.2. Biomarker Tests
    • 8.5.3. PCR Tests
  • 8.6. Pulse Oximetry
  • 8.7. Sputum Tests

9. Respiratory Diagnostics Market, by Patient Demographics

  • 9.1. Introduction
  • 9.2. Adult
  • 9.3. Geriatric
  • 9.4. Pediatric

10. Respiratory Diagnostics Market, by Offerings

  • 10.1. Introduction
  • 10.2. Equipment
    • 10.2.1. Body Plethysmographs
    • 10.2.2. Diagnostic Imaging Systems
    • 10.2.3. Gas Analysis Devices
    • 10.2.4. Spirometry Systems
  • 10.3. Services
  • 10.4. Software
    • 10.4.1. Data Analytics Software
    • 10.4.2. Imaging Analysis Software
    • 10.4.3. Pulmonary Function Testing (PFT) Software

11. Respiratory Diagnostics Market, by End Users

  • 11.1. Introduction
  • 11.2. Academic Institutions
  • 11.3. Diagnostic Laboratories
  • 11.4. Hospitals & Clinics
  • 11.5. Research Institutes

12. Americas Respiratory Diagnostics Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Respiratory Diagnostics Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Respiratory Diagnostics Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Becton, Dickinson, and Company
    • 15.3.2. Abbott Laboratories
    • 15.3.3. Adaltis S.r.l.
    • 15.3.4. Altona Diagnostics GmbH
    • 15.3.5. Bio-Rad Laboratories, Inc.
    • 15.3.6. bioMerieux S.A.
    • 15.3.7. Bioneer Corporation
    • 15.3.8. CerTest Biotec S.L.
    • 15.3.9. Daan Gene Co., Ltd.
    • 15.3.10. Diatech Pharmacogenetics srl
    • 15.3.11. Dragerwerk AG & Co. KGaA
    • 15.3.12. F. Hoffmann-La Roche Ltd.
    • 15.3.13. GE HealthCare Technologies, Inc.
    • 15.3.14. Hologic, Inc.
    • 15.3.15. Johnson & Johnson Services, Inc.
    • 15.3.16. Koninklijke Philips N.V.
    • 15.3.17. Masimo Corporation
    • 15.3.18. Medtronic PLC
    • 15.3.19. Merck KGaA
    • 15.3.20. ProAxsis by NetScientific PLC
    • 15.3.21. Quest Diagnostics Incorporated
    • 15.3.22. Quidel Corporation
    • 15.3.23. Sansure Biotech Inc.
    • 15.3.24. SDI Diagnostics, Inc.
    • 15.3.25. Seegene Inc.
    • 15.3.26. Siemens Healthineers AG
    • 15.3.27. ResMed Corp.
    • 15.3.28. Thermo Fisher Scientific Inc.
    • 15.3.29. Vitalograph Ltd.
    • 15.3.30. ZeptoMetrix LLC

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. RESPIRATORY DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. RESPIRATORY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. RESPIRATORY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHAI
  • FIGURE 24. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHSTATISTICS
  • FIGURE 25. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHCONTACTS
  • FIGURE 26. RESPIRATORY DIAGNOSTICS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. RESPIRATORY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ARTERIAL BLOOD GASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHEST X-RAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CT SCANS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MRI SCANS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIFFUSION CAPACITY TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG VOLUME TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ANTIGEN TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULSE OXIMETRY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPUTUM TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BODY PLETHYSMOGRAPHS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY GAS ANALYSIS DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DATA ANALYTICS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTING (PFT) SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 147. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 148. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 153. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 154. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 155. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 156. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 165. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 166. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 167. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 168. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 171. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 172. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 173. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 174. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 175. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 176. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 177. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 178. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 183. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 184. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 185. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 186. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 187. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 188. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 189. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 190. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 191. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 192. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 193. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 194. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 195. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 196. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 197. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 198. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 199. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 200. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 201. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 202. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 203. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 204. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 205. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 206. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 207. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 208. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 209. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 210. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 211. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 212. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 213. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 214. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 215. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 216. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 217. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 218. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 219. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 220. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 247. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 249. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 257. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 261. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 263. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 264. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 265. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 266. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 267. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 268. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 269. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 270. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 271. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 273. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 275. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 277. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 279. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 280. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 281. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 282. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 283. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 284. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 285. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 287. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 288. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 289. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 290. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 291. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 292. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 293. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 294. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 295. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 296. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 297. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 298. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 299. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 300. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 301. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 302. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
  • TABLE 303. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 304. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
  • TABLE 305. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2018-2024 (USD MILLION)
  • TABLE 306. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, 2025-2030 (USD MILLION)
  • TABLE 307. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2024 (USD MILLION)
  • TABLE 308. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2025-2030 (USD MILLION)
  • TABLE 309. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2018-2024 (USD MILLION)
  • TABLE 310. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG FUNCTION TESTS, 2025-2030 (USD MILLION)
  • TABLE 311. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2018-2024 (USD MILLION)
  • TABLE 312. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR TESTS, 2025-2030 (USD MILLION)
  • TABLE 313. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
  • TABLE 314. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 315. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 316. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OFFERINGS, 2025-2030 (USD MILLION)
  • TABLE 317. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 318. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 319. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 320. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
  • TABLE 321. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 322. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE,